Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma

Yutaka Hattori, Yurika Ikeda, Yuya Suzuki, Daiju Ichikawa, Maiko Matsushita

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)728-731
Number of pages4
JournalBritish Journal of Haematology
Issue number5
Publication statusPublished - 2014 Jun


  • Codon 72 polymorphism of TP53
  • Multiple myeloma
  • Prognosis
  • Thalidomide

ASJC Scopus subject areas

  • Hematology

Cite this